Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-11C]WAY-100635

Psychoneuroendocrinology

Volumn 45, Issue , 2014, Pages 1-10

  Kranz, Georg S ^a   Rami Mark, Christina ^a   Kaufmann, Ulrike ^b   Baldinger, Pia ^a   Hahn, Andreas ^a   Höflich, Anna ^a   Savli, Markus ^a   Stein, Patrycja ^a   Wadsak, Wolfgang ^a   Mitterhauser, Markus ^a   Winkler, Dietmar ^a   Lanzenberger, Rupert ^a   Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

Estradiol; Hormone replacement therapy; Positron emission tomography; Postmenopausal; Progesterone; Serotonin 1A receptor

Indexed keywords

17BETA ESTRADIOL VALERATE; CARBON 11; ESTRADIOL; ESTROGEN DERIVATIVE; FOLLITROPIN; LUTEINIZING HORMONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE C 11; PLACEBO; PRASTERONE SULFATE; PROGESTERONE; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG; CARBON; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PROTEIN BINDING; PYRIDINE DERIVATIVE;

ADULT; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; LUTEINIZING HORMONE BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BINDING; AGED; BLOOD; BRAIN CORTEX; DRUG EFFECTS; ESTROGEN THERAPY; METABOLISM; MIDDLE AGED;

AGED; CARBON RADIOISOTOPES; CEREBRAL CORTEX; DEHYDROEPIANDROSTERONE SULFATE; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; POSTMENOPAUSE; PROGESTERONE; PROTEIN BINDING; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEX HORMONE-BINDING GLOBULIN;

EID: 84901244764     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.03.004     Document Type: Article

References (51)

1. Adeosun S.O., Albert P.R., Austin M.C., Iyo A.H. 17beta-estradiol-induced regulation of the novel 5-HT1A-related transcription factors NUDR and Freud-1 in SH SY5Y cells. Cell. Mol. Neurobiol. 2012, 32:517-521.
2. Archer D.F., Sturdee D.W., Baber R., de Villiers T.J., Pines A., Freedman R.R., Gompel A., Hickey M., Hunter M.S., Lobo R.A., Lumsden M.A., MacLennan A.H., Maki P., Palacios S., Shah D., Villaseca P., Warren M. Menopausal hot flushes and night sweats: where are we now?. Climacteric 2011, 14:515-528.
3. Benmansour S., Weaver R.S., Barton A.K., Adeniji O.S., Frazer A. Comparison of the effects of estradiol and progesterone on serotonergic function. Biol. Psychiatry 2012, 71:633-641.
4. Bethea C.L., Mirkes S.J., Shively C.A., Adams M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol. Psychiatry 2000, 47:562-576.
5. Bethea C.L., Smith A.W., Centeno M.L., Reddy A.P. Long-term ovariectomy decreases serotonin neuron number and gene expression in free ranging macaques. Neuroscience 2011, 192:675-688.
6. Chavez C., Hollaus M., Scarr E., Pavey G., Gogos A., van den Buuse M. The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain Res. 2010, 1321:51-59.
7. Cheema D., Coomarasamy A., El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch. Gynecol. Obstet. 2007, 276:463-469.
8. Cohen L.S., Soares C.N., Poitras J.R., Prouty J., Alexander A.B., Shifren J.L. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am. J. Psychiatry 2003, 160:1519-1522.
9. Cohen L.S., Soares C.N., Vitonis A.F., Otto M.W., Harlow B.L. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch. Gen. Psychiatry 2006, 63:385-390.
10. Czesak M., Le Francois B., Millar A.M., Deria M., Daigle M., Visvader J.E., Anisman H., Albert P.R. Increased serotonin-1A (5-HT1A) autoreceptor expression and reduced raphe serotonin levels in deformed epidermal autoregulatory factor-1 (Deaf-1) gene knock-out mice. J. Biol. Chem. 2012, 287:6615-6627.
11. Gryglewski G., Lanzenberger R., Kranz G.S., Cumming P. Meta-analysis of molecular imaging of the serotonin transporter in major depression. J. Cereb. Blood Flow Metab. 2014, (in press).
12. Gundlah C., Lu N.Z., Bethea C.L. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl.) 2002, 160:271-282.
13. 11C]WAY-100635 for PET. Neuroimage 1998, 8:426-440.
14. 11C]WAY-100635 independent of arterial sampling. Neuroimage 2012, 62:199-206.
15. 11C]way-100635. Brain Res. 1997, 745:96-108.
16. Henderson J.A., Bethea C.L. Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 2008, 33:285-293.
17. Hirvonen J., Kajander J., Allonen T., Oikonen V., Nagren K., Hietala J. Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region. J. Cereb. Blood Flow Metab. 2007, 27:185-195.
18. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 2003, 23:1096-1112.
19. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
20. Jovanovic H., Karlsson P., Cerin A., Halldin C., Nordstrom A.L. 5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET. Psychiatry Res. 2009, 172:31-37.
21. Kenealy B.P., Kapoor A., Guerriero K.A., Keen K.L., Garcia J.P., Kurian J.R., Ziegler T.E., Terasawa E. Neuroestradiol in the hypothalamus contributes to the regulation of gonadotropin releasing hormone release. J. Neurosci. 2013, 33:19051-19059.
22. Kranz G.S., Hahn A., Savli M., Lanzenberger R. Challenges in the differentiation of midbrain raphe nuclei in neuroimaging research. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E2000.
23. Kugaya A., Epperson C.N., Zoghbi S., van Dyck C.H., Hou Y., Fujita M., Staley J.K., Garg P.K., Seibyl J.P., Innis R.B. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am. J. Psychiatry 2003, 160:1522-1524.
24. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
25. Lanzenberger R., Baldinger P., Hahn A., Ungersboeck J., Mitterhauser M., Winkler D., Micskei Z., Stein P., Karanikas G., Wadsak W., Kasper S., Frey R. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol. Psychiatry 2013, 18:93-100.
26. Lanzenberger R., Mitterhauser M., Kranz G.S., Spindelegger C., Wadsak W., Stein P., Moser U., Savli M., Kletter K., Kasper S. Progesterone level predicts serotonin-1a receptor binding in the male human brain. Neuroendocrinology 2011, 94:84-88.
27. Lu N.Z., Bethea C.L. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 2002, 27:12-24.
28. Maclennan A.H., Broadbent J.L., Lester S., Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst. Rev. 2004, CD002978.
29. Mani S.K. Signaling mechanisms in progesterone-neurotransmitter interactions. Neuroscience 2006, 138:773-781.
30. Micevych P., Sinchak K. Estradiol regulation of progesterone synthesis in the brain. Mol. Cell. Endocrinol. 2008, 290:44-50.
31. Mize A.L., Alper R.H. Acute and long-term effects of 17beta-estradiol on G(i/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding. Brain Res. 2000, 859:326-333.
32. Mize A.L., Poisner A.M., Alper R.H. Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 2001, 73:166-174.
33. Moses-Kolko E.L., Berga S.L., Greer P.J., Smith G., Cidis Meltzer C., Drevets W.C. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil. Steril. 2003, 80:554-559.
34. Moses-Kolko E.L., Wisner K.L., Price J.C., Berga S.L., Drevets W.C., Hanusa B.H., Loucks T.L., Meltzer C.C. Serotonin-1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil. Steril. 2008, 89:685-692.
35. Moses-Kolko E.L., Price J.C., Shah N., Berga S., Sereika S.M., Fisher P.M., Coleman R., Becker C., Mason N.S., Loucks T., Meltzer C.C. Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population. Neuropsychopharmacology 2011, 36:2729-2740.
36. Parsey R.V., Arango V., Olvet D.M., Oquendo M.A., Van Heertum R.L., John Mann J. Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J. Cereb. Blood Flow Metab. 2005, 25:785-793.
37. Parsey R.V., Ogden R.T., Miller J.M., Tin A., Hesselgrave N., Goldstein E., Mikhno A., Milak M., Zanderigo F., Sullivan G.M., Oquendo M.A., Mann J.J. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol. Psychiatry 2010, 68:170-178.
38. Pecins-Thompson M., Bethea C.L. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 1999, 89:267-277.
39. Rami-Mark C., Ungersboeck J., Haeusler D., Nics L., Philippe C., Mitterhauser M., Willeit M., Lanzenberger R., Karanikas G., Wadsak W. Reliable set-up for in-loop (11)C-carboxylations using Grignard reactions for the preparation of [carbonyl-(11)C]WAY-100635 and [(11)C]-(+)-PHNO. Appl. Radiat. Isot. 2013, 82:75-80.
40. Riecher-Rossler A. Oestrogen effects in schizophrenia and their potential therapeutic implications - review. Arch Womens Ment. Health 2002, 5:111-118.
41. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
42. Rybaczyk L.A., Bashaw M.J., Pathak D.R., Moody S.M., Gilders R.M., Holzschu D.L. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health 2005, 5:12.
43. Sanchez R.L., Reddy A.P., Centeno M.L., Henderson J.A., Bethea C.L. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques. Brain Res. Mol. Brain Res. 2005, 135:194-203.
44. Savli M., Bauer A., Mitterhauser M., Ding Y.S., Hahn A., Kroll T., Neumeister A., Haeusler D., Ungersboeck J., Henry S., Isfahani S.A., Rattay F., Wadsak W., Kasper S., Lanzenberger R. Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage 2012, 63:447-459.
45. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., Coker L.H. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291:2947-2958.
46. Smoller J.W., Pollack M.H., Wassertheil-Smoller S., Jackson R.D., Oberman A., Wong N.D., Sheps D. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch. Gen. Psychiatry 2007, 64:1153-1160.
47. Stein P., Baldinger P., Kaufmann U., Rami-Mark C., Hahn A., Hoflich A., Kranz G.S., Savli M., Wadsak W., Mitterhauser M., Winkler D., Kasper S., Lanzenberger R. Effects of progesterone and DHEAS on 5-HT1A receptor binding potential in pre- and postmenopausal women. Psychoneuroendocrinology 2014, (submitted for publication).
48. 11C]WAY-100635. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:2159-2168.
49. Sullivan E.L., Grayson B., Takahashi D., Robertson N., Maier A., Bethea C.L., Smith M.S., Coleman K., Grove K.L. Chronic consumption of a high-fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring. J. Neurosci. 2010, 30:3826-3830.
50. Varga J., Szabo Z. Modified regression model for the Logan plot. J. Cereb. Blood Flow Metab. 2002, 22:240-244.
51. 11C]WAY-100635. Radiochim. Acta 2007, 95:417-422.